FDA Cites Imaging Drug Web Sites, Draws "Respectful" Disagreement
This article was originally published in The Gray Sheet
Executive Summary
Bracco Diagnostics took down a promotional Web site recently, under protest, to comply with a request from FDA's Division of Drug Marketing, Advertising and Communications that it stop making "false and unsubstantiated claims" for its contrast media agent Isovue (iopamidol-370)